Remove Diagnostic Imaging Remove Nuclear Medicine Remove Radiation
article thumbnail

The rise of theranostics: Part 3 -- What is a theranostics center?

AuntMinnie

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We This oversight has led to program launch setbacks, Beyder explained.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

An assistant professor of radiology and radiological science, Francis Deng, MD, is the Johns Hopkins radiology department's co-director of medical student diagnostic radiology electives. His area of expertise is neuroradiology, with a special emphasis on diagnostic imaging of the head, neck, brain, and spine. Elliot Fishman, MD.

article thumbnail

IMV: PET procedure volumes continue strong growth trend

AuntMinnie

The top referring physicians sending patients for PET scans are medical oncologists, radiation oncologists, and pulmonologists. Follow IMV Medical Information on LinkedIn for more diagnostic imaging updates. Want to share your knowledge of medical imaging?

PET Scan 162
article thumbnail

Emerging Molecularly Targeted Radiation Agent Facilitates Bone Marrow Transplant in Patients with Acute Myeloid Leukemia

Diagnostic Imaging

A new modality that provides high-dose, molecularly targeted radiation to hematopoietic cells allows bone marrow transplant in patients with relapsed or refractory acute myeloid leukemia (AML) and may double one-year survival rates in comparison to conventional care, according to new research that garnered “Abstract of the Year” honors at the Society (..)

Radiation 119
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.